Literature DB >> 18458715

Genetic polymorphisms, drug metabolism and drug concentrations.

Gillian M Shenfield1.   

Abstract

Year:  2004        PMID： 18458715      PMCID： PMC1934960     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN： 0159-8090


× No keyword cloud information.
  22 in total

1.  Genetic variability in cytochrome P450 3A5 and in vivo cytochrome P450 3A activity: some answers but still questions.

Authors:  Grant R Wilkinson
Journal:  Clin Pharmacol Ther       Date:  2004-08       Impact factor: 6.875

Review 2.  Ethnic differences in reactions to drugs and xenobiotics. Acetylation.

Authors:  D A Evans
Journal:  Prog Clin Biol Res       Date:  1986

Review 3.  Clinical relevance of genetic polymorphisms in the human CYP2C subfamily.

Authors:  J A Goldstein
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

4.  Perhexiline maleate treatment for severe angina pectoris--correlations with pharmacokinetics.

Authors:  J D Horowitz; S T Sia; P S Macdonald; A J Goble; W J Louis
Journal:  Int J Cardiol       Date:  1986-11       Impact factor: 4.164

5.  CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori.

Authors:  Matthias Schwab; Elke Schaeffeler; Ulrich Klotz; Gerhard Treiber
Journal:  Clin Pharmacol Ther       Date:  2004-09       Impact factor: 6.875

6.  Population pharmacokinetic analysis of mirtazapine.

Authors:  Katja Grasmäder; Petra Louise Verwohlt; Kai-Uwe Kühn; Aleksandra Dragicevic; Olrik von Widdern; Astrid Zobel; Christoph Hiemke; Marcella Rietschel; Wolfgang Maier; Ulrich Jaehde; Marie Luise Rao
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

Review 7.  Clinical aspects of the MDR1 (ABCB1) gene polymorphism.

Authors:  Michel Eichelbaum; Martin F Fromm; Matthias Schwab
Journal:  Ther Drug Monit       Date:  2004-04       Impact factor: 3.681

8.  TPMT in the treatment of Crohn's disease with azathioprine.

Authors:  L Lennard
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

Review 9.  Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.

Authors:  Catia Marzolini; Erik Paus; Thierry Buclin; Richard B Kim
Journal:  Clin Pharmacol Ther       Date:  2004-01       Impact factor: 6.875

Review 10.  Clinical relevance of genetic polymorphisms in the human CYP2C9 gene.

Authors:  U I Schwarz
Journal:  Eur J Clin Invest       Date:  2003-11       Impact factor: 4.686
View more
  9 in total

1.  Acetylation pharmacogenetics and renal function in diabetes mellitus patients.

Authors:  S O Banjoko; K S Akinlade
Journal:  Indian J Clin Biochem       Date:  2010-08-25

Review 2.  Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV.

Authors:  Nomusa M Zondo; Parveen Sobia; Aida Sivro; Sinaye Ngcapu; Veron Ramsuran; Derseree Archary
Journal:  Front Genet       Date:  2022-09-29       Impact factor: 4.772

3.  Benefit of treatment of latent tuberculosis infection in individual patients.

Authors:  Kyle Fluegge
Journal:  Eur Respir J       Date:  2016-05       Impact factor: 16.671

4.  Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment.

Authors:  N B Bhatt; C Barau; A Amin; E Baudin; B Meggi; C Silva; V Furlan; B Grinsztejn; A Barrail-Tran; M Bonnet; A M Taburet
Journal:  Antimicrob Agents Chemother       Date:  2014-03-24       Impact factor: 5.191

5.  Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers.

Authors:  Yazun Bashir Jarrar; Ayat Ahmed Balasmeh; Wassan Jarrar
Journal:  Libyan J Med       Date:  2018-12       Impact factor: 1.657

6.  Network, Transcriptomic and Genomic Features Differentiate Genes Relevant for Drug Response.

Authors:  Janet Piñero; Abel Gonzalez-Perez; Emre Guney; Joaquim Aguirre-Plans; Ferran Sanz; Baldo Oliva; Laura I Furlong
Journal:  Front Genet       Date:  2018-09-25       Impact factor: 4.599

7.  Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy.

Authors:  Anick Bérard; Andrea Gaedigk; Odile Sheehy; Christina Chambers; Mark Roth; Pina Bozzo; Diana Johnson; Kelly Kao; Sharon Lavigne; Lori Wolfe; Dee Quinn; Kristen Dieter; Jin-Ping Zhao
Journal:  Front Pharmacol       Date:  2017-07-17       Impact factor: 5.810

8.  Pharmacogenetics: An Important Part of Drug Development with A Focus on Its Application.

Authors:  J T Oates; D Lopez
Journal:  Int J Biomed Investig       Date:  2018-05-27

9.  Synergism interaction between genetic polymorphisms in drug metabolizing enzymes and NSAIDs on upper gastrointestinal haemorrhage: a multicenter case-control study.

Authors:  Narmeen Mallah; Maruxa Zapata-Cachafeiro; Carmelo Aguirre; Eguzkiñe Ibarra-García; Itziar Palacios-Zabalza; Fernando Macías-García; María Piñeiro-Lamas; Luisa Ibáñez; Xavier Vidal; Lourdes Vendrell; Luis Martin-Arias; María Sáinz-Gil; Verónica Velasco-González; Manuel Bacariza-Cortiñas; Angel Salgado; Ana Estany-Gestal; Adolfo Figueiras
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.